Literature DB >> 8656445

Re:Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.

P L Lollini, P Nanni, C de Giovanni, G Nicoletti, L Landuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8656445     DOI： 10.1093/jnci/88.13.926

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.

Authors:  I Rossi; G Nicoletti; L Landuzzi; F Frabetti; C De Giovanni; P Nanni; P Musiani; M Ferrantini; F Belardelli; P L Lollini
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

Review 2.  IFN-γ and CD38 in Hyperprogressive Cancer Development.

Authors:  Stefania Angelicola; Francesca Ruzzi; Lorena Landuzzi; Laura Scalambra; Francesco Gelsomino; Andrea Ardizzoni; Patrizia Nanni; Pier-Luigi Lollini; Arianna Palladini
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

3.  Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).

Authors:  Shirley Tong; Maris A Cinelli; Naglaa Salem El-Sayed; He Huang; Anika Patel; Richard B Silverman; Sun Yang
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.